Cogent Biosciences, Inc. — Director's Dealing 2019

Nov 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Unum Therapeutics Inc. (UMRX)
CIK: 0001622229
Period of Report: 2019-11-19

Reporting Person: Green John L. (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-19	Restricted Stock Units	$	A	109459	Acquired		Common Stock (109459)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of UMRX common stock.

F2: The restricted stock units shall vest 25% on November 19, 2020, and then in equal monthly installments thereafter for the remaining 12 months, subject to the Reporting Person's continuous service with the Issuer.